Your doctor may first recommend that you:
- Try a vaginal moisturizer (Replens, Vagisil Feminine Moisturizer, others) to restore some moisture to your vaginal area. You may have to apply the moisturizer every two to three days. The effects of a moisturizer generally last a little longer than those of a lubricant.
- Use a water-based lubricant (glycerin-free versions of Astroglide, K-Y Intrigue, others) to reduce discomfort during intercourse. Choose products that don't contain glycerin because women who are sensitive to this chemical may experience burning and irritation. Avoid petroleum jelly or other petroleum-based products for lubrication if you're also using condoms. Petroleum can break down latex condoms on contact.
Bothersome symptoms that don't improve with over-the-counter treatments may be helped by:
- Topical (vaginal) estrogen. Vaginal estrogen has the advantage of being effective at lower doses and limiting your overall exposure to estrogen because less reaches your bloodstream. It may also provide better direct relief of symptoms than oral estrogen does.
- Oral estrogen. Estrogen taken by mouth enters your entire system. Ask your doctor to explain the risks vs. the benefits of oral estrogen.
Vaginal estrogen therapy comes in several forms. Because they all seem to work equally well, you and your doctor can determine which one is best for you.
- Vaginal estrogen cream. You insert this cream directly into your vagina with an applicator, usually at bedtime. Your doctor will let you know how much cream to use and how often to insert it. Typically women use it daily for one to three weeks and then one to three times a week thereafter. Although creams may offer faster relief than do other forms of vaginal estrogen, they can be messier.
- Vaginal estrogen ring. You or your doctor inserts a soft, flexible ring into the upper part of the vagina. The ring releases a consistent dose of estrogen while in place and needs to be replaced about every three months. Many women like the convenience this offers. A different, higher dose ring is considered a systemic rather than topical treatment.
- Vaginal estrogen tablet. You use a disposable applicator to place a vaginal estrogen tablet in your vagina. Your doctor will let you know how often to insert the tablet. You might, for instance, use it daily for the first two weeks and then twice a week thereafter.
Systemic estrogen therapy
If vaginal dryness is associated with other symptoms of menopause, such as moderate or severe hot flashes, your doctor may suggest estrogen pills, patches or gel, or a higher dose estrogen ring along with a progestin. Progestin is usually given as a pill, but combination estrogen-progestin patches also are available. Talk with your doctor to decide if hormone treatment is an option for you, taking into account any medical issues and family medical history.
Researchers are working to develop other treatments for vaginal atrophy because of concerns about the long-term potential for even small doses of estrogen to increase the risk of breast and endometrial cancer.
If you've had breast cancer
If you have a history of breast cancer, tell your doctor and consider these issues:
Apr. 23, 2013
- Nonhormonal treatments. Try moisturizers and lubricants as a first choice.
- Vaginal estrogen. In consultation with your cancer specialist (oncologist), your doctor might recommend low-dose vaginal estrogen if nonhormonal treatments don't help your symptoms. However, there is some concern that vaginal estrogen might increase your risk of the cancer coming back, especially if your breast cancer was hormonally sensitive.
- Systemic estrogen therapy. Systemic estrogen treatment generally isn't recommended, especially if your breast cancer was hormonally sensitive.
- AskMayoExpert. What causes urogenital atrophy? Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2012.
- Bachmann G, et al. Clinical manifestations and diagnosis of vaginal atrophy. http://www.uptodate.com/home. Accessed March 10, 2013.
- Bachmann G, et al. Treatment of vaginal atrophy. http://www.uptodate.com/home. Accessed March 10, 2013.
- AskMayoExpert. What are the symptoms of urogenital atrophy? Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2012.
- Pickar JH. Emerging therapies for postmenopausal vaginal atrophy. Maturitas. In press. Accessed March 21, 2013.
- AskMayoExpert. What are the treatment options for managing vaginal symptoms of urogenital atrophy in women with a history of breast cancer? Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2012.
- Papadakis MA, et al. Current Medical Diagnosis & Treatment 2013. 52nd ed. New York, N.Y.: The McGraw-Hill Companies; 2013. http://www.accessmedicine.com/resourceTOC.aspx?resourceID=1. Accessed March 19, 2013.
- The 2012 hormone therapy position statement of The North American Menopause Society. Menopause. 2012;19:257.
- Menopause and menopause treatments. U.S. Department of Health and Human Services Office on Women's Health. http://www.womenshealth.gov. Accessed March 8, 2013.
- Lentz GM, et al. Comprehensive Gynecology. 6th ed. Philadelphia, Pa.: Mosby Elsevier; 2012. http://www.mdconsult.com/books/linkTo?type=bookPage&isbn=978-0-323-06986-1&eid=4-u1.0-B978-0-323-06986-1..C2009-0-48752-X--TOP. Accessed March 10, 2013.
- AskMayoExpert. Are any tests available that can confirm or suggest vulvovaginal atrophy? Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2012.
- Leach MJ, et al. Black cohosh (Cimicifuga spp.) for menopausal symptoms (Review). Cochrane Database of Systematic Reviews. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007244.pub2/abstract. Accessed March 11, 2013.
- Casper RF, et al. Menopausal hot flashes. http://www.uptodate.com/home. Accessed March 11, 2013.
- Summary of Roundtable Meeting on Dietary Supplement-Drug Interactions. National Center for Complementary and Alternative Medicine. http://nccam.nih.gov/news/events/druginteraction?nav=gsa. March 21, 2013.
- Tan O, et al. Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: An up-to-date review. Menopause. 2012;19:109.
- Simon JA, et al. One-year long-term safety extension study of ospemifene for the treatment of vulvar and vaginal atrophy in postmenopausal women with a uterus. Menopause. 2013;20:1.